These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 38429828)

  • 1. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
    Zhou L; Lu Y; Liu W; Wang S; Wang L; Zheng P; Zi G; Liu H; Liu W; Wei S
    Exp Hematol Oncol; 2024 Mar; 13(1):26. PubMed ID: 38429828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
    Hong Y; Nam SM; Moon A
    Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug conjugate-based anticancer therapy - Current status and perspectives.
    Yang Y; Wang S; Ma P; Jiang Y; Cheng K; Yu Y; Jiang N; Miao H; Tang Q; Liu F; Zha Y; Li N
    Cancer Lett; 2023 Jan; 552():215969. PubMed ID: 36279982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers.
    Liu K; Li M; Li Y; Li Y; Chen Z; Tang Y; Yang M; Deng G; Liu H
    Mol Cancer; 2024 Mar; 23(1):62. PubMed ID: 38519953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence.
    Gogia P; Ashraf H; Bhasin S; Xu Y
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, efficacy and side effects of antibody‑drug conjugates for cancer therapy (Review).
    Sun T; Niu X; He Q; Liu M; Qiao S; Qi RQ
    Mol Clin Oncol; 2023 Jun; 18(6):47. PubMed ID: 37206431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to Antibody-Drug Conjugates.
    Pettinato MC
    Antibodies (Basel); 2021 Oct; 10(4):. PubMed ID: 34842621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences.
    Barreca M; Lang N; Tarantelli C; Spriano F; Barraja P; Bertoni F
    Explor Target Antitumor Ther; 2022; 3(6):763-794. PubMed ID: 36654819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Learn from antibody-drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy.
    Wu M; Huang W; Yang N; Liu Y
    Exp Hematol Oncol; 2022 Nov; 11(1):93. PubMed ID: 36348391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Molecule-Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs.
    Zhang J; Hu F; Aras O; Chai Y; An F
    ChemMedChem; 2024 Jun; 19(11):e202300720. PubMed ID: 38396351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in antibody-drug conjugates: A new era of targeted cancer therapy.
    Sau S; Alsaab HO; Kashaw SK; Tatiparti K; Iyer AK
    Drug Discov Today; 2017 Oct; 22(10):1547-1556. PubMed ID: 28627385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on the development of antibody-drug conjugates targeting ROR1 for hematological and solid cancers.
    Peng H
    Antib Ther; 2021 Oct; 4(4):222-227. PubMed ID: 34805745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivalent protein-drug conjugates - An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells.
    Porębska N; Ciura K; Chorążewska A; Zakrzewska M; Otlewski J; Opaliński Ł
    Biotechnol Adv; 2023 Oct; 67():108213. PubMed ID: 37453463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-Drug Conjugates: A Promising Novel Therapy for the Treatment of Ovarian Cancer.
    Manzano A; Ocaña A
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32784819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
    Tsuchikama K
    Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and challenges of antibody drug conjugates as novel form of chemotherapy.
    Fatima SW; Khare SK
    J Control Release; 2022 Jan; 341():555-565. PubMed ID: 34906604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-drug conjugates in lung cancer: dawn of a new era?
    Coleman N; Yap TA; Heymach JV; Meric-Bernstam F; Le X
    NPJ Precis Oncol; 2023 Jan; 7(1):5. PubMed ID: 36631624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
    Ponziani S; Di Vittorio G; Pitari G; Cimini AM; Ardini M; Gentile R; Iacobelli S; Sala G; Capone E; Flavell DJ; Ippoliti R; Giansanti F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.